Endothelial nitric oxide synthase in red blood cells: Key to a new erythrocrine function?

Redox Biology

Volumn 2, Issue 1, 2014, Pages 251-258

  Cortese Krott, Miriam M ^a   Kelm, Malte ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cardiovascular disease; ENOS; Nitric oxide; Red blood cells

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NOS3 PROTEIN, HUMAN; NOS3 PROTEIN, MOUSE;

CARDIOVASCULAR DISEASE; CELL FUNCTION; CORONARY ARTERY DISEASE; ENDOCRINE FUNCTION; ENZYME ACTIVITY; ERYTHROCRINE FUNCTION; ERYTHROCYTE; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ANOXIA; BIOSYNTHESIS; BLOOD; BLOOD STORAGE; BLOOD TRANSFUSION; DEFICIENCY; ENDOTHELIUM CELL; ENZYMOLOGY; ERYTHROCYTE LIFESPAN; HEMODYNAMICS; HOMEOSTASIS; KNOCKOUT MOUSE; MOUSE; PHYSIOLOGY; VASODILATATION;

ANIMALS; ANOXIA; BLOOD PRESERVATION; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; ERYTHROCYTE AGING; ERYTHROCYTES; HEMODYNAMICS; HOMEOSTASIS; HUMANS; MICE; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; SIGNAL TRANSDUCTION; VASODILATION;

EID: 84893411833     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2013.12.027     Document Type: Review

References (112)

1. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide, biology pathophysiology and pharmacology. Pharmacol. Rev. 1991, 43:109-142.
2. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288:373-376.
3. Ignarro L.J. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ. Res. 1989, 65:1-21.
4. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
5. Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989, 2:997-1000.
6. Moncada S. Nitric oxide in the vasculature: physiology and pathophysiology. Ann. New York Acad. Sci. 1997, 811:60-67. (discussion 67-69).
7. Bredt D.S., Snyder S.H. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 1994, 63:175-195.
8. Nathan C. Points of control in inflammation. Nature 2002, 420:846-852.
9. Griffith O.W., Stuehr D.J. Nitric oxide synthases: properties and catalytic mechanism. Annu. Rev. Physiol. 1995, 57:707-734.
10. Stuehr D.J. Enzymes of the l-arginine to nitric oxide pathway. J. Nutr. 2004, 134:2748S-2751S. (discussion 2765S-2767S).
11. Denninger J.W., Marletta M.A. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim. Biophys. Acta 1999, 1411:334-350.
12. Sessa W.C. eNOS at a glance. J. Cell Sci. 2004, 117:2427-2429.
13. Heiss C., Lauer T., Dejam A., Kleinbongard P., Hamada S., Rassaf T., Matern S., Feelisch M., Kelm M. Plasma nitroso compounds are decreased in patients with endothelial dysfunction. J. Am. Coll. Cardiol. 2006, 47:573-579.
14. Kleinbongard P., Dejam A., Lauer T., Rassaf T., Schindler A., Picker O., Scheeren T., Godecke A., Schrader J., Schulz R., Heusch G., Schaub G.A., Bryan N.S., Feelisch M., Kelm M. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic. Biol. Med. 2003, 35:790-796.
15. Rassaf T., Bryan N.S., Maloney R.E., Specian V., Kelm M., Kalyanaraman B., Rodriguez J., Feelisch M. NO adducts in mammalian red blood cells: too much or too little?. Nat Med. 2003, 9:481-482.
16. Rassaf T., Heiss C., Hendgen-Cotta U., Balzer J., Matern S., Kleinbongard P., Lee A., Lauer T., Kelm M. Plasma nitrite reserve and endothelial function in the human forearm circulation. Free Radic. Biol. Med. 2006, 41:295-301.
17. Milsom A.B., Fernandez B.O., Garcia-Saura M.F., Rodriguez J., Feelisch M. Contributions of nitric oxide synthases, dietary nitrite/nitrate, and other sources to the formation of NO signaling products. Antioxid. Redox Signal 2012, 17:422-432.
18. Bryan N.S., Fernandez B.O., Bauer S.M., Garcia-Saura M.F., Milsom A.B., Rassaf T., Maloney R.E., Bharti A., Rodriguez J., Feelisch M. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nature Chem. Biol. 2005, 1:290-297.
19. Crawford J.H., Isbell T.S., Huang Z., Shiva S., Chacko B.K., Schechter A.N., rley-Usmar V.M., Kerby J.D., Lang J.D., Kraus D., Ho C., Gladwin M.T., Patel R.P. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 2006, 107:566-574.
20. van Faassen E.E., Bahrami S., Feelisch M., Hogg N., Kelm M., Kim-Shapiro D.B., Kozlov A.V., Li H., Lundberg J.O., Mason R., Nohl H., Rassaf T., Samouilov A., Slama-Schwok A., Shiva S., Vanin A.F., Weitzberg E., Zweier J., Gladwin M.T. Nitrite as regulator of hypoxic signaling in mammalian physiology. Med. Res. Rev. 2009, 29:683-741.
21. Totzeck M., Hendgen-Cotta U.B., Luedike P., Berenbrink M., Klare J.P., Steinhoff H.J., Semmler D., Shiva S., Williams D., Kipar A., Gladwin M.T., Schrader J., Kelm M., Cossins A.R., Rassaf T. Nitrite regulates hypoxic vasodilation via myoglobin-dependent nitric oxide generation. Circulation 2012, 126:325-334.
22. Cosby K., Partovi K.S., Crawford J.H., Patel R.P., Reiter C.D., Martyr S., Yang B.K., Waclawiw M.A., Zalos G., Xu X., Huang K.T., Shields H., Kim-Shapiro D.B., Schechter A.N., Cannon Iii R.O., Gladwin M.T. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 2003, 9:1498-1505.
23. Gladwin M.T., Shelhamer J.H., Schechter A.N., Pease-Fye M.E., Waclawiw M.A., Panza J.A., Ognibene F.P., Cannon Iii R.O. Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc. Natl. Acad. Sci. USA 2000, 97:11482-11487.
24. Lundberg J.O., Gladwin M.T., Ahluwalia A., Benjamin N., Bryan N.S., Butler A., Cabrales P., Fago A., Feelisch M., Ford P.C., Freeman B.A., Frenneaux M., Friedman J., Kelm M., Kevil C.G., Kim-Shapiro D.B., Kozlov A.V., Lancaster J.R., Lefer D.J., McColl K., McCurry K., Patel R.P., Petersson J., Rassaf T., Reutov V.P., Richter-Addo G.B., Schechter A., Shiva S., Tsuchiya K., van Faassen E.E., Webb A.J., Zuckerbraun B.S., Zweier J.L., Weitzberg E. Nitrate and nitrite in biology, nutrition and therapeutics. Nat. Chem. Biol. 2009, 5:865-869.
25. Shiva S., Gladwin M.T. Nitrite mediates cytoprotection after ischemia/reperfusion by modulating mitochondrial function. Basic Res. Cardiol. 2009, 104:113-119.
26. Hendgen-Cotta U.B., Merx M.W., Shiva S., Schmitz J., Becher S., Klare J.P., Steinhoff H.J., Goedecke A., Schrader J., Gladwin M.T., Kelm M., Rassaf T. Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 2008, 105:10256-10261.
27. Murillo D., Kamga C., Mo L., Shiva S. Nitrite as a mediator of ischemic preconditioning and cytoprotection. Nitric Oxide 2011, 25:70-80.
28. Huang P.L., Huang Z., Mashimo H., Bloch K.D., Moskowitz M.A., Bevan J.A., Fishman M.C. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995, 377:239-242.
29. Shesely E.G., Maeda N., Kim H.S., Desai K.M., Krege J.H., Laubach V.E., Sherman P.A., Sessa W.C., Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 1996, 93:13176-13181.
30. Godecke A., Decking U.K., Ding Z., Hirchenhain J., Bidmon H.J., Godecke S., Schrader J. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ. Res. 1998, 82:186-194.
31. Sase K., Michel T. Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci. 1995, 57:2049-2055.
32. Cortese-Krott M.M., Rodriguez-Mateos A., Sansone R., Kuhnle G.G., Thasian-Sivarajah S., Krenz T., Horn P., Krisp C., Wolters D., Heiss C., Kroncke K.D., Hogg N., Feelisch M., Kelm M. Human red blood cells at work: identification and visualization of erythrocytic eNOS activity in health and disease. Blood 2012, 120:4229-4237.
33. Aubry J.P., Dugas N., Lecoanet-Henchoz S., Ouaaz F., Zhao H., Delfraissy J.F., Graber P., Kolb J.P., Dugas B., Bonnefoy J.Y. The 25-kDa soluble CD23 activates type III constitutive nitric oxide-synthase activity via CD11b and CD11c expressed by human monocytes. J. Immunol. 1997, 159:614-622.
34. Mühl H., Pfeilschifter J. Endothelial nitric oxide synthase: a determinant of TNFalpha production by human monocytes/macrophages. Biochem. Biophys. Res. Commun. 2003, 310:677-680.
35. Saluja R., Jyoti A., Chatterjee M., Habib S., Verma A., Mitra K., Barthwal M.K., Bajpai V.K., Dikshit M. Molecular and biochemical characterization of nitric oxide synthase isoforms and their intracellular distribution in human peripheral blood mononuclear cells. Biochim. Biophys. Acta. 2011, 1813:1700-1707.
36. Radomski M.W., Palmer R.M., Moncada S. An l-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA 1990, 87:5193-5197.
37. Horn P., Cortese-Krott M.M., Amabile N., Hundsdorfer C., Kroncke K.D., Kelm M., Heiss C. Circulating microparticles carry a functional endothelial nitric oxide synthase that is decreased in patients with endothelial dysfunction. J. Am. Heart Assoc. 2013, 2:e003764.
38. Gambaryan S., Kobsar A., Hartmann S., Birschmann I., Kuhlencordt P.J., MÜLler Esterl W., Lohmann S.M., Walter U. NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity. J. Thromb. Haemost. 2008, 6:1376-1384.
39. Ozüyaman B., Gödecke A., Küsters S., Kirchhoff E., Scharf R.E., Schrader J. Endothelial nitric oxide synthase plays a minor role in inhibition of arterial thrombus formation. Thromb. Haemost. 2005.
40. Kleinbongard P., Schulz R., Rassaf T., Lauer T., Dejam A., Jax T., Kumara I., Gharini P., Kabanova S., Ozuyaman B., Schnurch H.G., Godecke A., Weber A.A., Robenek M., Robenek H., Bloch W., Rosen P., Kelm M. Red blood cells express a functional endothelial nitric oxide synthase. Blood 2006, 107:2943-2951.
41. Eligini S., Porro B., Lualdi A., Squellerio I., Veglia F., Chiorino E., Crisci M., Garlasche A., Giovannardi M., Werba J.P., Tremoli E., Cavalca V. Nitric oxide synthetic pathway in red blood cells is impaired in coronary artery disease. PloS one 2013, 8:e66945.
42. Helms C., Kim-Shapiro D.B. Hemoglobin-mediated nitric oxide signaling. Free Radic. Biol. Med. 2013, 61c:464-472.
43. Webb A., Milsom A., Rathod K., Chu W., Qureshi S., Lovell M., Lecomte F., Perrett D., Raimondo C., Khoshbin E., Ahmed Z., Uppal R., Benjamin N., Hobbs A., Ahluwalia A. Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia: role for xanthine oxidoreductase and endothelial nitric oxide synthase. Circ. Res. 2008, 103:957-964.
44. Herold S. The outer-sphere oxidation of nitrosyliron(II)hemoglobin by peroxynitrite leads to the release of nitrogen monoxide. Inorg. Chem. 2004, 43:3783-3785.
45. Jia L., Bonaventura C., Bonaventura J., Stamler J.S. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996, 380:221-226.
46. Gladwin M.T., Lancaster J.R., Freeman B.A., Schechter A.N. Nitric oxide's reactions with hemoglobin: a view through the SNO-storm. Nat. Med. 2003, 9:496-500.
47. Dejam A., Hunter C.J., Pelletier M.M., Hsu L.L., Machado R.F., Shiva S., Power G.G., Kelm M., Gladwin M.T., Schechter A.N. Erythrocytes are the major intravascular storage sites of nitrite in human blood. Blood 2005, 106:734-739.
48. Vitturi D.A., Teng X., Toledo J.C., Matalon S., Lancaster J.R., Patel R.P. Regulation of nitrite transport in red blood cells by hemoglobin oxygen fractional saturation. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H1398-H1407.
49. Nagababu E., Ramasamy S., Albernethy R., Rifkind M. Active nitric oxide produced in the red cell under hypoxic conditions by deoxyhemoglobin-mediated nitrite reduction. J. Biol. Chem. 2003, 278:46349-46356.
50. Zweier J.L., Wang P., Samouilov A., Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nat. Med. 1995, 1:804-809.
51. Aamand R., Dalsgaard T., Jensen F.B., Simonsen U., Roepstorff A., Fago A. Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H2068-H2074.
52. Patel R.P., Hogg N., Kim-Shapiro D.B. The potential role of the red blood cell in nitrite-dependent regulation of blood flow. Cardiovasc. Res. 2011, 89:507-515.
53. Owusu B.Y., Stapley R., Patel R.P. Nitric oxide formation versus scavenging: the red blood cell balancing act. J. Physiol. 2012, 590:4993-5000.
54. Locovei S., Bao L., Dahl G. Pannexin 1 in erythrocytes: function without a gap. Proc. Natl. Acad. Sci. USA 2006, 103:7655-7659.
55. Sridharan M., Adderley S.P., Bowles E.A., Egan T.M., Stephenson A.H., Ellsworth M.L., Sprague R.S. Pannexin 1 is the conduit for low oxygen tension-induced ATP release from human erythrocytes. AJP: Heart Circ. Physiol. 2010, 299:H1146-H1152.
56. Forsyth A.M., Wan J., Owrutsky P.D., Abkarian M., Stone H.A. Multiscale approach to link red blood cell dynamics, shear viscosity, and ATP release. Proc. Natl. Acad. Sci. 2011, 108:10986-10991.
57. Wan J., Forsyth A.M., Stone H.A. Red blood cell dynamics: from cell deformation to ATP release. Integr. Biol. (Camb) 2011, 3:972-981.
58. Forsyth A.M., Wan J., Owrutsky P.D., Abkarian M., Stone H.A. Multiscale approach to link red blood cell dynamics, shear viscosity, and ATP release. Proc. Natl. Acad. Sci. USA 2011, 108:10986-10991.
59. Ellsworth M.L., Forrester T., Ellis C.G., Dietrich H.H. The erythrocyte as a regulator of vascular tone. Am. J. Physiol. Heart Circ. Physiol. 1995, 269:H2155-H2161.
60. Ellsworth M.L., Sprague R.S. Regulation of blood flow distribution in skeletal muscle: role of erythrocyte-released ATP. J. Physiol. 2012, 590:4985-4991.
61. Gonzalez-Alonso J. ATP as a mediator of erythrocyte-dependent regulation of skeletal muscle blood flow and oxygen delivery in humans. J. Physiol. 2012, 590:5001-5013.
62. Bhattacharya S., Chakraborty P.S., Basu R.S., Kahn N.N., Sinha A.K. Purification and properties of insulin-activated nitric oxide synthase from human erythrocyte membranes. Arch. Physiol. Biochem. 2001, 109:441-449.
63. Mihov D., Vogel J., Gassmann M., Bogdanova A. Erythropoietin activates nitric oxide synthase in murine erythrocytes. Am. J. Physiol. Cell Physiol. 2009, 297:C378-C388.
64. Jubelin B.C., Gierman J.L. Erythrocytes may synthesize their own nitric oxide. AJH 1996, 9:1214-1219.
65. Kang E.S., Ford K., Grokulsky G., Wang Y.B., Chiang T.M., Acchiardo S.R. Normal circulating adult human red blood cells contain inactive NOS proteins. J. Lab Clin. Med. 2000, 135:444-451.
66. Wood K.C., Cortese-Krott M.M., Kovacic J.C., Noguchi A., Liu V.B., Wang X., Raghavachari N., Boehm M., Kato G.J., Kelm M., Gladwin M.T. Circulating blood endothelial nitric oxide synthase contributes to the regulation of systemic blood pressure and nitrite homeostasis. Arterioscler Thromb. Vasc. Biol. 2013, 33:1861-1871.
67. Deliconstantinos G., Villiotou V., Stavrides J.C., Salemes N., Gogas J. Nitric oxide and peroxynitrite production by human erythrocytes: a causative factor of toxic anemia in breast cancer patients. Anticancer Res. 1995, 15:1435-1446.
68. Yang J., Gonon A.T., Sjoquist P.O., Lundberg J.O., Pernow J. Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity. Proc. Natl. Acad. Sci. USA 2013, 110:15049-15054.
69. Chen L.Y., Mehta J.L. Evidence for the presence of l-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function. J. Cardiovasc. Pharmacol. 1998, 32:57-61.
70. Yang B.C., Nichols W.W., Mehta J.L. Cardioprotective Effects of Red Blood Cells on Ischemia and Reperfusion Injury in Isolated Rat Heart: Release of Nitric Oxide as a Potential Mechanism. J. Cardiovasc. Pharmacol. Therapeut. 1996, 1:297-306.
71. Böhmer A., Beckmann B., Sandmann J., Tsikas D. Doubts concerning functional endothelial nitric oxide synthase in human erythrocytes. Blood 2012, 119:1322-1323.
72. Metha J.L., Metha P., Li D. Nitric oxide synthase in adult red blood cells: vestige of an earlier age or a biologically active enzyme?. J. Lab Clin. Med. 2000, 135:430-431.
73. Shiva S., Wang X., Ringwood L.A., Xu X., Yuditskaya S., Annavajjhala V., Miyajima H., Hogg N., Harris Z.L., Gladwin M.T. Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat. Chem. Biol. 2006, 2:486-493.
74. Cortese-Krott M.M., Rodriguez-Mateos A., Kuhnle G.G., Brown G., Feelisch M., Kelm M. A multilevel analytical approach for detection and visualization of intracellular NO production and nitrosation events using diaminofluoresceins. Free Radic. Biol. Med. 2012, 53:2146-2158.
75. Gladwin M.T., Schechter A., Kim-Shapiro D.B., Patel R., Hogg N., Shiva S., Cannon R., Kelm M., Wink D., Espey M., Oldfield E., Pluta R., Freeman B., Lancaster J., Feelisch M., Lundberg J.O. The emerging biology of the nitrite anion in signaling, blood flow and hypoxic nitric oxide homeostasis. Nat. Chem. Biol. 2005, 1:308-314.
76. Lohman A.W., Weaver J.L., Billaud M., Sandilos J.K., Griffiths R., Straub A.C., Penuela S., Leitinger N., Laird D.W., Bayliss D.A., Isakson B.E. S-nitrosylation inhibits pannexin 1 channel function. J. Biol. Chem. 2012, 287:39602-39612.
77. Song C.Z., Wang Q.W., Song C.C. Erythrocyte-based analgesic peptides. Regul. Pept. 2013, 180:58-61.
78. Sprague R.S., Stephenson A.H., Dimmitt R.A., Weintraub N.L., Branch C.A., McMurdo L., Lonigro A.J. Effect of l-NAME on pressure-flow relationships in isolated rabbit lungs: role of red blood cells. Am. J. Physiol 1995, 269:H1941-H1948.
79. Bor-Kucukatay M., Wenby R.B., Meiselman H.J., Baskurt O.K. Effects of nitric oxide on red blood cell deformability. Am. J. Physiol. Heart Circul. Physiol. 2003, 284:H1577-H1584.
80. Horn P., Cortese-Krott M.M., Keymel S., Kumara I., Burghoff S., Schrader J., Kelm M., Kleinbongard P. Nitric oxide influences red blood cell velocity independently of changes in the vascular tone. Free Radic. Res. 2011, 45:653-661.
81. Cao Z., Bell J.B., Mohanty J.G., Nagababu E., Rifkind J.M. Nitrite enhances RBC hypoxic ATP synthesis and the release of ATP into the vasculature: a new mechanism for nitrite-induced vasodilation. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1494-H1503.
82. Merx M.W., van de Sandt G.S., Cortese-Krott A.M., Ohlig M.M., Stern J., Rassaf M., Gödecke T., Gladwin A., Kelm M.T., M. Depletion of circulating blood NOS3 increases severity of myocardial infarction and left ventricular dysfunction. Basic Res. Cardiol. 2013, 109(1):398-408.
83. Ii M., Nishimura H., Iwakura A., Wecker A., Eaton E., Asahara T., Losordo D.W. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation 2005, 111:1114-1120.
84. Hendgen-Cotta U.B., Luedike P., Totzeck M., Kropp M., Schicho A., Stock P., Rammos C., Niessen M., Heiss C., Lundberg J.O., Weitzberg E., Kelm M., Rassaf T. Dietary nitrate supplementation improves revascularization in chronic ischemia. Circulation 2012, 126:1983-1992.
85. Levett D.Z., Fernandez B.O., Riley H.L., Martin D.S., Mitchell K., Leckstrom C.A., Ince C., Whipp B.J., Mythen M.G., Montgomery H.E., Grocott M.P., Feelisch M. The role of nitrogen oxides in human adaptation to hypoxia. Scient. Rep. 2011, 1:109.
86. Umbrello M., Dyson A., Feelisch M., Singer M. The key role of nitric oxide in hypoxia: hypoxic vasodilation and energy supply-demand matching. Antioxid Redox Signal 2013, 19:1690-1710.
87. Cosby K., Partovi K.S., Crawford J.H., Patel R.P., Reiter C.D., Martyr S., Yang B.K., Waclawiw M.A., Zalos G., Xu X., Huang K.T., Shields H., Kim-Shapiro D.B., Schechter A.N., Cannon R.O., Gladwin M.T. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 2003, 9:1498-1505.
88. Maher A.R., Milsom A.B., Gunaruwan P., Abozgula K., Ahmed I., Weaver R.A., Thomas P., Ashrafian H., Born G.V., James P.E., Frenneaux M.P. Hypoxic modulation of exogenous nitrite-induced vasodilation in humans. Circulation 2008, 117:670-677.
89. Duranski M.R., Greer J.J., Dejam A., Jaganmohan S., Hogg N., Langsotn W., Patel R.P., Yet S.F., Wang X., Kevil C.G., Gladwin M.T., Lefer D.J. Cytoprotective effects of nitirite during in vivo ischemia-reperfusion of the heart and liver. J. Clin. Invest. 2005, 115:1232-1240.
90. Dezfulian C., Raat N., Shiva S., Gladwin M.T. Role of the anion nitrite in ischemia-reperfusion cytorprotection and therapeutics. Cardiovasc. Res. 2007, 75:327-338.
91. Frerart F., Lobysheva I., Gallez B., Dessy C., Feron O. Vascular caveolin deficiency supports the angiogenic effects of nitrite, a major end product of nitric oxide metabolism in tumors. Mol. Cancer Res. MCR 2009, 7:1056-1063.
92. Heiss C., Schanz A., Amabile N., Jahn S., Chen Q., Wong M.L., Rassaf T., Heinen Y., Cortese-Krott M., Grossman W., Yeghiazarians Y., Springer M.L. Nitric oxide synthase expression and functional response to nitric oxide are both important modulators of circulating angiogenic cell response to angiogenic stimuli. Arterioscler. Thromb. Vasc. Biol. 2010, 30:2212-2218.
93. Felker G.M., Allen L.A., Pocock S.J., Shaw L.K., McMurray J.J., Pfeffer M.A., Swedberg K., Wang D., Yusuf S., Michelson E.L., Granger C.B. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J. Am. Coll. Cardiol. 2007, 50:40-47.
94. Patel K.V., Semba R.D., Ferrucci L., Newman A.B., Fried L.P., Wallace R.B., Bandinelli S., Phillips C.S., Yu B., Connelly S., Shlipak M.G., Chaves P.H., Launer L.J., Ershler W.B., Harris T.B., Longo D.L., Guralnik J.M. Red cell distribution width and mortality in older adults: a meta-analysis. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2010, 65:258-265.
95. Tonelli M., Sacks F., Arnold M., Moye L., Davis B., Pfeffer M. Cholesterol, f. t. Investigators, R. E. T. Relation between red Blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008, 117:163-168.
96. Sabatine M.S., Morrow D.A., Giugliano R.P., Burton P.B., Murphy S.A., McCabe C.H., Gibson C.M., Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005, 111:2042-2049.
97. Kulier A., Levin J., Moser R., Rumpold-Seitlinger G., Tudor I.C., Snyder-Ramos S.A., Moehnle P., Mangano D.T. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007, 116:471-479.
98. Anand I.S. Anemia and chronic heart failure implications and treatment options. J. Am. Coll. Cardiol. 2008, 52:501-511.
99. Najjar S.S., Rao S.V., Melloni C., Raman S.V., Povsic T.J., Melton L., Barsness G.W., Prather K., Heitner J.F., Kilaru R., Gruberg L., Hasselblad V., Greenbaum A.B., Patel M., Kim R.J., Talan M., Ferrucci L., Longo D.L., Lakatta E.G., Harrington R.A. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA: J. Am. Med. Assoc. 2011, 305:1863-1872.
100. Koch C.G., Li L., Sessler D.I., Figueroa P., Hoeltge G.A., Mihaljevic T., Blackstone E.H. Duration of red-cell storage and complications after cardiac surgery. New Engl. J. Med. 2008, 358:1229-1239.
101. Bassand J.P., Afzal R., Eikelboom J., Wallentin L., Peters R., Budaj A., Fox K.A., Joyner C.D., Chrolavicius S., Granger C.B., Mehta S., Yusuf S. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. Eur. Heart J. 2010, 31:50-58.
102. Lee J.S., Gladwin M.T. Bad blood: The risks of red cell storage. Nat. Med. 2010, 16:381-382.
103. Tinmouth A., Fergusson D., Yee I.C., Hebert P.C. Clinical consequences of red cell storage in the critically ill. Transfusion 2006, 46:2014-2027.
104. Marik P.E., Corwin H.L. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Critical Care Med. 2008, 36:2667-2674.
105. Donadee C., Raat N.J., Kanias T., Tejero J., Lee J.S., Kelley E.E., Zhao X., Liu C., Reynolds H., Azarov I., Frizzell S., Meyer E.M., Donnenberg A.D., Qu L., Triulzi D., Kim-Shapiro D.B., Gladwin M.T. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011, 124:465-476.
106. Gladwin M.T., Kim-Shapiro D.B. Storage lesion in banked blood due to hemolysis-dependent disruption of nitric oxide homeostasis. Curr. Opin. Hematol. 2009, 16:515-523.
107. Liu C., Zhao W., Christ G.J., Gladwin M.T., Kim-Shapiro D.B. Nitric oxide scavenging by red cell microparticles. Free Radic. Biol. Med. 2013, 65:1164-1173.
108. Bennett-Guerrero E., Veldman T.H., Doctor A., Telen M.J., Ortel T.L., Reid T.S., Mulherin M.A., Zhu H., Buck R.D., Califf R.M., McMahon T.J. Evolution of adverse changes in stored RBCs. Proc. Natl. Acad. Sci. USA 2007, 104:17063-17068.
109. Doctor A., Spinella P. Effect of processing and storage on red blood cell function in vivo. Semin. Perinatol. 2012, 36:248-259.
110. Hare G.M., Tsui A.K., Crawford J.H., Patel R.P. Is methemoglobin an inert bystander, biomarker or a mediator of oxidative stress-the example of anemia?. Redox Biol. 2013, 1:65-69.
111. Kanias T., Wang L., Lippert A., Kim-Shapiro D.B., Gladwin M.T. Red blood cell endothelial nitric oxide synthase does not modulate red blood cell storage hemolysis. Transfusion 2013, 53:981-989.
112. Lang K.S., Lang P.A., Bauer C., Duranton C., Wieder T., Huber S.M., Lang F. Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem. 2005, 15:195-202.